2 Comments

  1. JBA

    “In Britain inept hospital management overspends £500 million a year just on basic supplies. Whilst doctors commonly prescribe generic drugs that are two or three generations old when there are more modern drugs available that do a far better job.”

    once again you cherry pic your arguments while either ignoring or being oblivious of the other side of the coin.

    the fact is, these companies often introduce drugs that are functionally no better than what was available before, but solely to beat the expiration of patents.

    for instance, while by now GPs should be able to prescribe a generic drug based on Gaviscon, the company behind it withdrew it before its patent expired and replaced it with Gaviscon Plus. which is just the same thing but more concentrated and offering no real benefits to Gaviscon. but that’s what GPs now have to prescribe – so in fact the NHS is being forced to overspend, because of such chicanery.

    yes, there are new fantastic drugs that would provide great benefits to those who need them, and if only the NHS wasn’t compelled to spend more than should be necessary on the staples, then they would have more funds available to buy them.

    as for immorality, these companies have much to learn themselves, with their life-is-cheap, let’s-use-them-as-guinea-pigs activities in the third-world.


  2. @JBA
    As usual you are wrong. There are plenty of Gaviscon generics available: Gelusil, Maalox, Mylanta, Wingel.
    The system for the NHS prescription channel failed with the generic name assignation. Something that Gaviscon’s manufacturers exploited.
    But the fundamental problem, as usual, was the inane working of the NHS.

Comments are closed.